What is OrthAlign?
OrthAlign specializes in the design and manufacturing of advanced computer-assisted surgery technology, specifically engineered to enhance alignment accuracy during hip and knee replacement procedures. By providing surgeons with the Lantern platform, the company facilitates total hip, total knee, revision knee, and partial knee arthroplasties with a focus on accessibility and operational efficiency. The firm's market position is defined by its commitment to empowering healthcare providers with user-friendly, data-driven tools that improve patient outcomes while maintaining cost-effectiveness in any operating room environment.
How much funding has OrthAlign raised?
OrthAlign has raised a total of $37.2M across 5 funding rounds:
Series A
$7.2M
Private Equity
$4M
Series C
$15M
Series D
$10M
Debt
$1M
Series A (2009): $7.2M with participation from Research Corporation
Private Equity (2010): $4M, investors not publicly disclosed
Series C (2014): $15M supported by River Cities Capital Funds and Mutual Capital Partners Funds
Series D (2017): $10M featuring Mutual Capital Partners, River Cities Capital Funds, Research, and California Technology Ventures, LLC
Debt (2020): $1M backed by PPP
Key Investors in OrthAlign
River Cities Capital Funds
RC Capital is a growth equity firm focused on building high-potential healthcare companies by leveraging the interplay of medical devices, healthcare services, and healthcare IT.
Mutual Capital Partners
Mutual Capital Partners is a Cleveland-based venture capital fund that focuses on investing in early-stage software and medical device companies in the Midwest.
California Technology Ventures, LLC
California Technology Ventures specializes in direct investments in technology and life science companies, focusing on building world-class enterprises through strategic guidance.
What's next for OrthAlign?
Looking ahead, OrthAlign is positioned to leverage its major enterprise-level funding to further expand its technological footprint and deepen its integration into the global surgical ecosystem. The strategic focus will likely center on scaling the adoption of the Lantern platform, enhancing R&D capabilities to address complex arthroplasty challenges, and strengthening its competitive advantage in the medical device sector. As the company continues to refine its surgical navigation tools, it remains well-equipped to capitalize on the increasing demand for precision-based, minimally invasive orthopedic interventions, ensuring long-term value creation for its stakeholders and improved clinical results for patients.
See full OrthAlign company page
